Insider · CIK 0001279281
Ivana Magovcevic-Liebisch
ceopresidentofficerdirector
Files at QTRX (Quanterix Corp), ACRV (Acrivon Therapeutics, Inc.), VIGL (Vigil Neuroscience, Inc.). First filing Dec 5, 2024, latest Dec 19, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$28k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Vigil Neuroscience, Inc. | $8,400 5,000 shares | +2% | - | |
| 38Weak | Vigil Neuroscience, Inc. | $8,350 5,000 shares | +2% | - | |
| 33Weak | Vigil Neuroscience, Inc. | $12k 5,000 shares | +2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | QTRX Quanterix Corp | MOption exercise Common Stock | +4,224 | - | - | 15,883 | 10 d ago |
| Oct 2, 2026 | QTRX Quanterix Corp | MOption exercise Restricted Stock Unitderivative | -4,224 | $0.00 | $0 | 4,352 | 10 d ago |
| Jun 13, 2025 | ACRV Acrivon Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,275 | $0.00 | $0 | 20,275 | Jun 17, 2025 |
| Dec 19, 2024 | VIGL Vigil Neuroscience, Inc. | POpen-market purchase Common Stock | +5,000 | $1.68 | $8,400 | 222,687 | Dec 19, 2024 |
| Dec 18, 2024 | VIGL Vigil Neuroscience, Inc. | POpen-market purchase Common Stock | +5,000 | $1.67 | $8,350 | 217,687 | Dec 18, 2024 |
| Dec 5, 2024 | VIGL Vigil Neuroscience, Inc. | POpen-market purchase Common Stock | +5,000 | $2.34 | $12k | 212,687 | Dec 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.